Nijveldt, R., Teerlink, T., van der Hoven, B., Siroen, M., Kuik, D., Rauwerda, J., & van Leeuwen, P. (2003). Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. BioMed Central.
Citação norma ChicagoNijveldt, RJ, T. Teerlink, B. van der Hoven, MPC Siroen, DJ Kuik, JA Rauwerda, e PAM van Leeuwen. Asymmetrical Dimethylarginine (ADMA) in Critically Ill Patients: High Plasma ADMA Concentration Is an Independent Risk Factor of ICU Mortality. BioMed Central, 2003.
Citação norma MLANijveldt, RJ, et al. Asymmetrical Dimethylarginine (ADMA) in Critically Ill Patients: High Plasma ADMA Concentration Is an Independent Risk Factor of ICU Mortality. BioMed Central, 2003.